# CryoLife agrees to acquire JOTEC AG

CryoLife entered into a definitive agreement to acquire JOTEC AG, a German developer of endovascular stent grafts and surgical grafts, to access the $2 billion global stent graft market.

- Type: Acquisition
- Announced: 2017-10-03
- Where: Germany
- Status: announced
- Products: endovascular stent grafts, cardiac and vascular surgical grafts
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [CryoLife](https://endata.com/companies/27346.md) (acquirer)
- [JOTEC](https://endata.com/companies/27347.md) (target)

## Sources

- [cryolife.com](https://www.cryolife.com/cryolife-announces-definitive-agreement-acquire-jotec/), 2017-10-03: "We believe this acquisition will enable CryoLife to deliver sustained, high single-digit revenue growth, while also diversifying our revenues into a significantly larger addressable market."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.